Neue Suche | Kongressdetail
mail
Druckansicht
 
 

3rd Annual Ligase Targeting Drug Development Summit

Evvnt Promotion / evvnt
-
11.04.2023 - 13.04.2023  Hilton Boston Logan Airport, One Hotel Drive, 02128 Boston, Massachusetts, USA
Time: 9:00 am to 5:00 pm
 
Kongressthemen
From discovery to clinical development, the field of protein degradation is booming with excitement, with a whole host of investments and new companies joining the effort to successfully degrade unwanted or undrugged targets with key roles in a broad range of diseases from oncology to CNS, through to autoimmune.

Despite this, key challenges remain to rapidly and successfully discover novel and underexploited Ubiquitin E3 ligases.
Wissenschaftliche Fach-Gesellschaft
Hanson Wade
Anmerkungen
Speakers: Kirby Swatek, Principal Investigator, University of Dundee, Ian Churcher, Chief Scientific Officer, Amphista Therapeutics, David Duda, Senior Scientist, Johnson and Johnson and more.
 

Anfragen und Anmeldung:

https://go.evvnt.com/1450513-2?pid=4832
Herr Alex Domingo
 
Kategorien
Gesundheitsversorgung, Public Health
Sprache
Englisch
Kongressgebühr
USD 2599.00 - USD 5846.00
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien
 
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."

AGEM - Arbeitsgemeinschaft Ethnologie und MedizinAlumni Club Medizinische Universität WienEuropean Public Health Association (EUPHA)newTreeCentro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio SanitarioHelix - Forschung & Beratung WienÖsterreichische Gesellschaft für Public HealthAMREF - African Medical and Research Foundation